Habush Habush & Rottier S.C.® > Blog > Product Liability > FDA rules on Kim Kardashian pharmaceutical tweet

FDA rules on Kim Kardashian pharmaceutical tweet

Posted under Product Liability

The FDA ordered one of Kim Kardashian’s Instagram and Twitter posts be removed last week as it violated regulations that require any promotional efforts for pharmaceutical products to include risk information. Kardashian, acting as an official spokesperson for the drug, posted to her 34 million Twitter followers and 42 million Instagram followers about her use of DICLEGIS, a drug produced by Duchesnay USA and designed to counteract morning sickness in pregnant women.

In response to the FDA’s letter on August 7, a Dechesnay spokeswoman, Laney Landsman, confirmed Kardashian’s status as a paid spokesperson for the company and made assurances that the posts were removed promptly. She also mentioned that “Duchesnay is…working out a plan to submit to the FDA.”

This recent issue has highlighted specific problems created for FDA regulators by social media, including the struggle to convey pertinent information under strict character limits as well as the speed with which companies can deliver materials to consumers.

If you have been harmed by a pharmaceutical product due to a lack of information or otherwise, you may be able to seek compensation for your associated pain and suffering. Do not hesitate to contact a Madison personal injury lawyer at Habush Habush & Rottier S.C.® by calling (800) 242-2874 today.